Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/5118
Hepatic p63 regulates steatosis via IKK beta/ER stress
Porteiro, Begona | Fondevila, Marcos F. | Delgado, Teresa C. | Iglesias, Cristina | Imbernon, Monica | Iruzubieta, Paula | Crespo, Javier | Zaballos, Angel ISCIII | Ferno, Johan | Gonzalez-Teran, Barbara CNIC | Matesanz, Nuria CNIC | Hernandez-Cosido, Lourdes | Marcos, Miguel | Tovar, Sulay | Vidal, Anxo | Sanchez-Ceinos, Julia | Malagon, Maria M. | Pombo, Celia | Zalvide, Juan | Carracedo, Arkaitz | Buque, Xabier | Dieguez, Carlos | Sabio, Guadalupe CNIC | Lopez, Miguel | Aspichueta, Patricia | Martinez-Chantar, Maria L. | Nogueiras, Ruben
Nat Commun. 2017; 8:15111
p53 family members control several metabolic and cellular functions. The p53 ortholog p63 modulates cellular adaptations to stress and has a major role in cell maintenance and proliferation. Here we show that p63 regulates hepatic lipid metabolism. Mice with liver-specific p53 deletion develop steatosis and show increased levels of p63. Down-regulation of p63 attenuates liver steatosis in p53 knockout mice and in diet-induced obese mice, whereas the activation of p63 induces lipid accumulation. Hepatic overexpression of N-terminal transactivation domain TAp63 induces liver steatosis through IKK beta activation and the induction of ER stress, the inhibition of which rescues the liver functions. Expression of TAp63, IKK beta and XBP1s is also increased in livers of obese patients with NAFLD. In cultured human hepatocytes, TAp63 inhibition protects against oleic acid-induced lipid accumulation, whereas TAp63 overexpression promotes lipid storage, an effect reversible by IKK beta silencing. Our findings indicate an unexpected role of the p63/IKK beta/ER stress pathway in lipid metabolism and liver disease.
FATTY LIVER-DISEASE | ENDOPLASMIC-RETICULUM STRESS | UNFOLDED PROTEIN RESPONSE | B-KINASE-BETA | ER STRESS | KAPPA-B | LIPID-METABOLISM | MOUSE MODEL | IN-VIVO | P53